Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Muscle Nerve ; 49(1): 134-8, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23893323

RESUMEN

INTRODUCTION: Erythromelalgia due to heterozygous gain-of-function SCN9A mutations usually presents as a pure sensory-autonomic disorder characterized by recurrent episodes of burning pain and redness of the extremities. METHODS: We describe a patient with an unusual phenotypic presentation of gross motor delay, childhood-onset erythromelalgia, extreme visceral pain episodes, hypesthesia, and self-mutilation. The investigation of the patient's motor delay included various biochemical analyses, a comparative genomic hybridization array (CGH), electromyogram (EMG), and muscle biopsy. Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced. RESULTS: The EMG, CGH, and biochemical tests were negative. The biopsy showed an axonal neuropathy and neurogenic atrophy. Sequencing of SCN9A revealed a heterozygous missense mutation in exon 7; p.I234T. CONCLUSIONS: This is a case of global motor delay and erythromelalgia associated with SCN9A. The motor delay may be attributed to the extreme pain episodes or to a developmental perturbation of proprioceptive inputs.


Asunto(s)
Trastornos de la Destreza Motora/genética , Mutación Missense/genética , Canal de Sodio Activado por Voltaje NAV1.7/genética , Índice de Severidad de la Enfermedad , Trastornos Somatomorfos/genética , Carbamazepina/uso terapéutico , Preescolar , Comorbilidad , Eritromelalgia/tratamiento farmacológico , Eritromelalgia/epidemiología , Eritromelalgia/genética , Femenino , Humanos , Hipoestesia/tratamiento farmacológico , Hipoestesia/epidemiología , Hipoestesia/genética , Mexiletine/uso terapéutico , Trastornos de la Destreza Motora/tratamiento farmacológico , Trastornos de la Destreza Motora/epidemiología , Trastornos Somatomorfos/tratamiento farmacológico , Trastornos Somatomorfos/epidemiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA